Brainstorm Cell Therapeutics Inc., of New York, appointed David Setboun executive vice president and chief operating officer. Ralph Kern was named president.
Harpoon Therapeutics Inc., of South San Francisco, appointed Andrew R. Robbins and Joseph S. Bailes to its board.
Locana Inc., of San Diego, appointed Micah Mackison chief business officer.
Plus Therapeutics Inc., of Austin, Texas, appointed Gregory Stein senior vice president of clinical development.
Rockwell Medical Inc., of Wixom, Mich., appointed Robert S. Radie to its board.
Sutura Therapeutics Ltd., of Birkenhead, U.K., appointed Mark Beards CEO.